Corient Private Wealth LP Takes Position in Prestige Consumer Healthcare Inc. $PBH

Corient Private Wealth LP acquired a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 25,423 shares of the company’s stock, valued at approximately $1,202,000.

A number of other institutional investors also recently modified their holdings of PBH. BlackRock Inc. acquired a new position in Prestige Consumer Healthcare in the second quarter worth $370,187,000. Rice Hall James & Associates LLC bought a new position in shares of Prestige Consumer Healthcare during the second quarter worth $32,602,000. The Manufacturers Life Insurance Company acquired a new position in shares of Prestige Consumer Healthcare in the 2nd quarter valued at $31,135,000. Norges Bank acquired a new position in shares of Prestige Consumer Healthcare in the 4th quarter valued at $36,954,000. Finally, Bank of America Corp DE bought a new stake in shares of Prestige Consumer Healthcare in the 2nd quarter valued at $26,277,000. Institutional investors own 99.95% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on the company. Weiss Ratings downgraded Prestige Consumer Healthcare from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, June 25th. Zacks Research upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, August 10th. Canaccord Genuity Group dropped their price target on Prestige Consumer Healthcare from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Friday, May 15th. Finally, Oppenheimer cut Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating in a report on Thursday, May 14th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $70.75.

Prestige Consumer Healthcare Trading Down 0.7%

Shares of NYSE:PBH opened at $52.17 on Friday. The firm has a market cap of $2.47 billion, a price-to-earnings ratio of 14.61, a PEG ratio of 1.65 and a beta of 0.33. Prestige Consumer Healthcare Inc. has a 12 month low of $42.62 and a 12 month high of $71.07. The company’s fifty day simple moving average is $50.76 and its 200 day simple moving average is $54.14. The company has a quick ratio of 1.99, a current ratio of 3.23 and a debt-to-equity ratio of 1.06.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.98 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.09. Prestige Consumer Healthcare had a return on equity of 11.39% and a net margin of 15.57%.The company had revenue of $265.71 million for the quarter, compared to analyst estimates of $253.02 million. During the same period in the previous year, the company posted $0.90 earnings per share. The company’s quarterly revenue was up 6.5% compared to the same quarter last year. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. As a group, research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.56 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare, Inc is a leading manufacturer and marketer of branded over-the-counter (OTC) healthcare products. The company focuses on developing, acquiring and commercializing a diverse portfolio of non-prescription remedies designed to address common consumer health needs, including pain relief, cold and cough, digestive health, eye care, skin care and women’s health.

Key brands in Prestige’s portfolio include Clear Eyes (eye health), Carmex (lip care), Chloraseptic (sore throat relief), Dramamine (motion sickness), Rolaids (antacid), Monistat (women’s health), BC Powder (pain relief), Little Remedies (pediatric cold and gas relief) and TheraTears (dry eye therapy).